Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | RecQ helicase | 0.0174 | 0.4564 | 0.4539 |
Echinococcus granulosus | geminin | 0.0165 | 0.426 | 0.9096 |
Brugia malayi | ATP-dependent DNA helicase, RecQ family protein | 0.0072 | 0.1204 | 0.1861 |
Schistosoma mansoni | bcl-2 homologous antagonist/killer (bak) | 0.0081 | 0.149 | 0.3426 |
Leishmania major | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.0093 | 0.1899 | 0.5 |
Entamoeba histolytica | recQ family helicase, putative | 0.0093 | 0.1899 | 1 |
Echinococcus granulosus | bloom syndrome protein | 0.0174 | 0.4564 | 1 |
Trypanosoma brucei | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.0093 | 0.1899 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0165 | 0.426 | 1 |
Trichomonas vaginalis | DNA helicase recq, putative | 0.0174 | 0.4564 | 1 |
Treponema pallidum | ATP-dependent DNA helicase | 0.0037 | 0.0046 | 0.5 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0116 | 0.2659 | 0.2626 |
Echinococcus granulosus | EGFP:Bcl2 fusion protein | 0.0081 | 0.149 | 0.0851 |
Loa Loa (eye worm) | apoptosis regulator protein | 0.0081 | 0.149 | 0.1451 |
Giardia lamblia | Sgs1 DNA helicase, putative | 0.0072 | 0.1204 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0436 | 0.0392 |
Schistosoma mansoni | hypothetical protein | 0.0081 | 0.149 | 0.3426 |
Schistosoma mansoni | blooms syndrome DNA helicase | 0.0138 | 0.336 | 0.7864 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0072 | 0.1204 | 0.4422 |
Plasmodium falciparum | ADP-dependent DNA helicase RecQ | 0.0153 | 0.3869 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0081 | 0.149 | 0.3426 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0116 | 0.2659 | 0.2626 |
Brugia malayi | Apoptosis regulator proteins, Bcl-2 family protein | 0.0081 | 0.149 | 0.2553 |
Schistosoma mansoni | DNA helicase recq5 | 0.0072 | 0.1204 | 0.2748 |
Echinococcus granulosus | Bcl 2 ous antagonist:killer | 0.0081 | 0.149 | 0.0851 |
Schistosoma mansoni | hypothetical protein | 0.0165 | 0.426 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0116 | 0.2659 | 0.5386 |
Echinococcus multilocularis | bloom syndrome protein | 0.0174 | 0.4564 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0049 | 0.0436 | 0.0392 |
Echinococcus multilocularis | geminin | 0.0165 | 0.426 | 0.9096 |
Loa Loa (eye worm) | hypothetical protein | 0.0072 | 0.1204 | 0.1163 |
Plasmodium vivax | ADP-dependent DNA helicase RecQ, putative | 0.0118 | 0.2711 | 1 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0072 | 0.1204 | 0.4422 |
Loa Loa (eye worm) | hypothetical protein | 0.0081 | 0.149 | 0.1451 |
Trypanosoma cruzi | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.0093 | 0.1899 | 1 |
Schistosoma mansoni | apoptosis regulator bax | 0.0081 | 0.149 | 0.3426 |
Schistosoma mansoni | DNA helicase recq1 | 0.0072 | 0.1204 | 0.2748 |
Schistosoma mansoni | hypothetical protein | 0.0081 | 0.149 | 0.3426 |
Brugia malayi | Bloom's syndrome protein homolog | 0.0174 | 0.4564 | 1 |
Echinococcus multilocularis | EGFP:Bcl2 fusion protein | 0.0081 | 0.149 | 0.0851 |
Entamoeba histolytica | recQ family DNA helicase | 0.0037 | 0.0046 | 0.0241 |
Brugia malayi | ATP-dependent DNA helicase, RecQ family protein | 0.0072 | 0.1204 | 0.1861 |
Trichomonas vaginalis | DNA helicase recq1, putative | 0.0174 | 0.4564 | 1 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0117 | 0.2665 | 1 |
Echinococcus multilocularis | Bcl 2 ous antagonist:killer | 0.0081 | 0.149 | 0.0851 |
Loa Loa (eye worm) | ATP-dependent DNA helicase | 0.0072 | 0.1204 | 0.1163 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.